Chemistry:Sulfanegen

From HandWiki
Revision as of 12:10, 9 September 2023 by NBrushPhys (talk | contribs) (correction)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Sulfanegen
Sulfanegen.svg
Names
IUPAC name
2,5-Dihydroxy-1,4-dithiane-2,5-dicarboxylic acid
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
UNII
Properties
C6H8O6S2
Molar mass 240.24 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
Tracking categories (test):

Sulfanegen is an experimental antidote for cyanide poisoning.[1] It is being studied as a prodrug for 3-mercaptopyruvic acid (3-MP). 3-MP has been studied as a potential treatment for cyanide poisoning, but the half-life is too short for it to be clinically effective.[2] Instead, alternative chemicals such as sulfanegen, the hemithioacetal cyclic dimer of 3-MP, are being evaluated that produce 3-MP in vivo to compensate for the short half-life of 3-MP itself.[3]

Sulfanegen has been shown to be effective in animal studies.[4] It is being studied as the disodium salt, sulfanegen sodium,[3][5] and the triethanolamine salt, sulfanegen TEA.[6] One advantage various sulfanegen formulations have over existing treatments for acute cyanide poisoning is that they might be administered by intramuscular injection or orally[1] rather than by intravenous infusion.[6]

References

  1. 1.0 1.1 "Scientists Discover Fast-Acting Cyanide Antidote". Medgadget. Dec 27, 2007. http://www.medgadget.com/2007/12/scientists_discover_fastacting_cyanide_antidote.html. Retrieved 2015-07-12. 
  2. Nagahara, N; Li, Q; Sawada, N (2003). "Do antidotes for acute cyanide poisoning act on mercaptopyruvate sulfurtransferase to facilitate detoxification?". Current Drug Targets. Immune, Endocrine and Metabolic Disorders 3 (3): 198–204. doi:10.2174/1568008033340162. PMID 12871026. 
  3. 3.0 3.1 Brenner, M; Kim, JG; Lee, J; Mahon, SB; Lemor, D; Ahdout, R; Boss, GR; Blackledge, W et al. (2010). "Sulfanegen sodium treatment in a rabbit model of sub-lethal cyanide toxicity". Toxicology and Applied Pharmacology 248 (3): 269–76. doi:10.1016/j.taap.2010.08.002. PMID 20705081. 
  4. Chan, A; Crankshaw, DL; Monteil, A; Patterson, SE; Nagasawa, HT; Briggs, JE; Kozocas, JA; Mahon, SB et al. (2011). "The combination of cobinamide and sulfanegen is highly effective in mouse models of cyanide poisoning". Clinical Toxicology 49 (5): 366–73. doi:10.3109/15563650.2011.584879. PMID 21740135. 
  5. Belani, KG; Singh, H; Beebe, DS; George, P; Patterson, SE; Nagasawa, HT; Vince, R (2012). "Cyanide toxicity in juvenile pigs and its reversal by a new prodrug, sulfanegen sodium". Anesthesia and Analgesia 114 (5): 956–61. doi:10.1213/ANE.0b013e31824c4eb5. PMID 22392971. 
  6. 6.0 6.1 "New Antidote for Cyanide Found". Yahoo News. February 1, 2013. https://news.yahoo.com/antidote-cyanide-found-132827160.html.